One in four of all deaths in the United Kingdom is caused by cancer ([Coleman *et al*, 1999](#bib5){ref-type="other"}). Although the majority of these deaths occur in the elderly, cancer represents the most common cause of death at ages 13--29 years. Approximately 2500 teenagers and young adults (TYAs) died from cancer in England and Wales in the 4-year period 2002--2005. Little is known about the aetiology of cancers in such young people, though; it is likely that it differs from that in older adults ([Birch, 2005](#bib2){ref-type="other"}, pp 13--31).

We carried out detailed analyses of mortality rates by cancer group, sex, age and time period in persons aged 13--29 years in England and Wales, to identify the highest mortalities and lowest reductions in mortality over time; these, it is hoped, will assist with targeting of clinical resources and service planning.

METHODS
=======

Mortality data on neoplasms in England and Wales from 1981 to 2005 were provided by the Office for National Statistics, London (ONS); those covered malignant neoplasms, benign tumours and neoplasms of uncertain behaviour, in those aged 13--29 years. For each observation, age at death, sex, and diagnosis coded according to the International Classification of Diseases (ICD) were included. Data on cases registered from 1981 to 2001, a period that spans both the ICD Ninth Revision (ICD-9) ([World Health Organization, 1977](#bib20){ref-type="other"}) and ICD Tenth Revision (ICD-10) ([World Health Organization, 1992](#bib21){ref-type="other"}) coding epochs at the ONS, were released by the English Cancer Information System ([Office for National Statistics, 2004](#bib12){ref-type="other"}) along with the tabulation for the conversion from the earlier ICD-9 to ICD-10. Direct translation between ICD-9 and ICD-10 at the 4-digit level for all codes was not possible. We, therefore, used the ICD-10 codes up to the third digit. For comparison purposes, we also considered incidence data on all registered neoplasms diagnosed in England from 1979 to 2003 inclusive, supplied by the National Cancer Intelligence Centre, ONS, London ([Office for National Statistics, 2006b](#bib10){ref-type="other"}).

Mid-year estimates, by single year of age and sex, of the resident population in England and Wales for the time period 1981--2005 were obtained, based on the national censuses ([Office for National Statistics, 2007](#bib11){ref-type="other"}). Number of deaths and population estimates were tabulated by age, sex and time period. The age groups were 13--14, 15--19, 20--24 and 25--29 years. The time span was divided into five quinquennia. Thirteen main diagnostic groups were defined as shown in [Table 1](#tbl1){ref-type="table"}, three of which were further subclassified giving 14 groups in all and for each, mortality rates were calculated. The European standard population was used for direct standardisation of the rates ([Quinn *et al*, 2005](#bib14){ref-type="other"}). Throughout this report rates are given per million person-years (mpy).

Heterogeneity between sexes, age groups, and time periods was tested for by using a *χ*^2^ test statistic. Age and temporal trends was tested for, by using a single degree of freedom *χ*^2^ statistic ([Armitage, 1955](#bib1){ref-type="other"}); the estimate of the percent change per year of age (PCYA) was obtained by using a linear regression of the natural logarithm of the rates; similarly, in the temporal analysis the annual percent change (APC) was estimated by using a weighted linear regression of the natural logarithm of the age-adjusted rates where the weights were given by the inverse of the estimated variance of the response variable ([Kim *et al*, 2000](#bib6){ref-type="other"}). Significance level was set at 5%.

The results of the separate stratified analyses were successively assessed with Poisson additive models ([Wood, 2006](#bib19){ref-type="other"}), including main effects, interaction terms, and non-linear temporal trends simultaneously. The statistical analyses were performed using Stata v. 9.2 ([StataCorp, 2005](#bib17){ref-type="other"}) and the software R ([R Development Core Team, 2006](#bib15){ref-type="other"}).

RESULTS
=======

A total of 20 026 deaths were registered over 25-year period in people aged 13--29 years with ICD-10 codes C00-D48, of which 875 were from benign, uncertain or unknown behaviour tumours. There were approximately 303 million person-years at risk. Overall, the mortality rate was 65.6 per mpy ([Table 2](#tbl2){ref-type="table"}). Malignant tumours of the central nervous system (CNS) showed the highest mortality rate (8.5), followed by myeloid and monocytic leukaemia (MML) (6.6), lymphoid leukaemia (LL) (6.4), malignant bone tumours (bone) (5.4) and non-Hodgkin\'s lymphoma (NHL) (5.2). These groups together accounted for almost 50% of all deaths under study.

Overall, the mortality rate for males (72.4) was 23% higher than for females (58.6), and significantly higher in all the specified groups except breast and genitourinary (GU) organs, where females had higher rates; there was no significant heterogeneity by sex for liver cancer, melanoma, GU sites other than gonads and cervix, thyroid and non-malignant neoplasms of the CNS. There were large disproportions of rates between males and females for cancers of the lip, oral cavity and pharynx, respiratory organs, bone and lymphomas and leukaemias. In these groups, the ratio of rates in males compared to females was between 1.5 and 2.2.

The mortality differed between age groups for all specified diagnostic groups except thyroid and other endocrine glands ([Table 3](#tbl3){ref-type="table"}). The rates for breast and cervical cancer increased by 50% for each additional year of age. Marked increases across age groups were also observed for digestive organs (excluding liver), melanoma of skin and testicular cancer, whereas for bone cancer decreases on average by nearly 8% per year of age, the largest drop among the diagnostic groups. Lymphomas and MML rates increased rates with age, with the largest increases at ages 13--19 years. Mortality for LL peaked at age 15--19 years. For Hodgkin\'s lymphoma (HL), mortality for persons aged 25--29 years was 11 times higher than the rate for those aged 13--14 years.

When using the Poisson regression approach, few groups showed a significant interaction between sex and age. For bone, the relative risk in males compared to females increased with age, from 0.8 (95% confidence interval, CI, 0.6--1.1) at 13--14 years to 2.1 (95% CI 1.6--2.8) at 25--29 years. For NHL, the relative risk decreased by age, in males being three (95% CI 1.7--5.3) times higher at 13--14 years and 1.7 (95% CI 1.4--2) times higher at 25--29 years.

Mortality for all cancers combined decreased over time by 1.86% on average each year ([Table 4](#tbl4){ref-type="table"}). Numbers decreasing from about 1000 per year in 1981--1985 to a little over 600 per year in 2001--2005 period. Testicular cancer showed the largest APC (−6.31), followed by HL (−5.12), cancer of respiratory and intra-thoracic organs (−4.26), and cervical cancer (−4.07). Neither the total nor the sex-specific mortality rates for bone showed a significant trend over time. Further analyses revealed that the rates, after decreasing in the first three time periods, increased in the last 10 years at age 20--24 years (APC 1.43, CI 0.16--2.72); this was also supported by the Poisson regression.

Groups with the highest mortality (CNS, MML, LL, bone, NHL) differed from those with the highest incidence (HL, testis, melanoma, CNS, cervix) ([Table 5](#tbl5){ref-type="table"}). CNS, MML, LL, bone and soft tissue were all in the top 10 for mortality and were between 3 and 8 rank places higher than for incidence. The ratio of incidence to mortality varied from 16 : 1 for testis and 11 : 1 for thyroid cancer to where the rates are similar, as for liver. The ratio for MML, LL, and bone was below 2 : 1. Testicular and cervical cancer, melanoma, and HL were among the top five groups with the highest incidence between 1979 and 2003 but below the 5th position for mortality between 1981 and 2005, with deaths numbering much below that of new cases.

In 2002--2005, approximately 2500 TYAs in England died from neoplasms, of which 2341 were coded as malignant, making cancer the commonest disease-related cause of death at these ages, accounting for approximately 12% of all deaths and exceeded only by deaths from transport accidents, though at 13--14 years neoplasmic deaths outnumbered deaths from any other cause ([Table 6](#tbl6){ref-type="table"}). Deaths from all causes by sex and age group showed a heterogeneous distribution.

Among the 875 deaths coded as being due to benign (275) or uncertain and unknown behaviour (600) neoplasms, 166 involved endocrine glands, 49 middle ear, respiratory and intrathoracic organs, 57 mesothelial and soft tissue, 31 haemopoietic and 23 of GU organs and 549 other sites.

DISCUSSION
==========

This is the first study to present detailed analyses of cancer mortality in TYAs in England and Wales and makes use of recent national data over a 25-year period. The introduction of ICD-10 in 2001 had an impact on the analysis of trends in cancer mortality ([Brock *et al*, 2004](#bib4){ref-type="other"}). Comparability ratios provide a measure of the effect of changes in coding practice that may vary by site and age. Approximated estimates of variations in rates of TYA mortality trends showed substantial robustness of the data to the introduction of the ICD-10 coding system. The results demonstrate that cancer mortality in TYAs has decreased over time. Yet, cancer is still the most common disease-related cause of death in this age group. Moreover, the sites of most lethal cancers differ from those at higher ages ([Office for National Statistics, 2006a](#bib9){ref-type="other"}). Some of the deaths due to benign neoplasms or those of uncertain behaviour may have been miscoded or reported inaccurately. However, the small proportion of deaths so assigned to ill-defined sites supports the robustness of the data.

Major mortality reductions occurred for cancers of (i) respiratory and intrathoracic organs, mainly bronchus and lung, (ii) GU organs, cervical and testicular cancer in particular, and (iii) HL; whereas cancers of digestive organs, soft tissue, and CNS showed lower decreases in rates and less favourable incidence to mortality ratios. There were no corresponding incidence falls of these cancers in TYAs and in contrast some temporal increases have been noted ([Birch, 2005](#bib2){ref-type="other"}). The marked reductions in mortality must therefore be due to well-documented improvements in survival, particularly from testis cancer and HL ([Coleman *et al*, 1999](#bib5){ref-type="other"}). Given our study period, it is likely that cervical screening will have contributed to the reduction in cervix cancer mortality. That from melanoma remained relatively constant over time, in spite of an increase in incidence, and was higher in males. In contrast, incidence was higher in females indicating that survival for melanoma is higher in females and has increased over time. Increased public and physician awareness of melanoma in young people may have contributed to these changes.

Previous national studies of cancer mortality in England and Wales presented data up to 1997 ([Swerdlow *et al*, 2001](#bib18){ref-type="other"}) and 2003 ([Quinn *et al*, 2001](#bib13){ref-type="other"}; [Rowan *et al*, 2005](#bib16){ref-type="other"}) and included figures for broad and variable age groups (e.g. 15--34, 20--44) depending on cancer site. Furthermore, not all relevant cancer sites were reported in detail for example bone, soft tissue, thyroid, HL, MML, LL and liver ([Quinn *et al*, 2001](#bib13){ref-type="other"}); bone, soft tissue, MML, LL ([Swerdlow *et al*, 2001](#bib18){ref-type="other"}), thereby preventing direct comparisons. [Levi *et al* (2003)](#bib7){ref-type="other"} reported mortality trends at 15--24 years in Europe, including the United Kingdom but compared, 1965--1969 with 1995--1998, and only for selected diagnostic groups (bone, soft tissue, testis, NHL, HL, and all leukaemias combined), again, precluding direct comparison.

A recent study from the United States covering the period 1975--2000 included some mortality at ages 15--29 years ([Bleyer *et al*, 2006](#bib3){ref-type="other"}), but was primarily on incidence and survival. In general, the trends were compatible with the present study though some differences were apparent. Thus, decreases in mortality at 15--29 years were reported for melanoma, colorectal carcinoma and testicular cancers; there were smaller reductions for CNS tumours and breast cancer. For liver cancer there was an overall decrease, but mortality increased in the more recent years, but time trends for other groups were not reported. In the present study, up to year 2000, no reduction in mortality from colorectal cancer was seen, but there was a steady decrease in breast cancer and mortality from liver cancer was stable. These differences may, at least in part, be due to differences in the ethnic mix in the United States, England, and Wales.

The recent guidance on improving outcomes in children and young people with cancer, published by the National Institute for Health and Clinical Excellence ([National Collaborating Centre for Cancer, 2005](#bib8){ref-type="other"}) noted the lack of available comprehensive data on cancers in TYAs. The present report provides this for mortality in England and Wales. The results highlight diagnostic groups, which present the greatest clinical challenges, including those in which the ratio of incidence to mortality is low, indicating poor survival and those groups with little or no reductions in mortality over time. The four leading causes of cancer death, CNS tumours, MML, LL, and bone cancers, all have low incidence to mortality ratios. Furthermore, over the 25-year study period, mortality in CNS and bone tumours has decreased by less than 1%. These observations may assist with resource allocation and the setting of clinical targets.
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###### 

Diagnostic groups based on the ICD-10 codes used for the analysis of the mortality data of persons aged 13--29 years in England and Wales from 1981 to 2005

  **Description**                                                                                                     
  --------------------------------------------------------------------- --------------------------------------------- ----------------------------------------
  Lip, oral cavity and pharynx                                          C00--C14                                      
  Digestive organs                                                                                                    C15--C26
                                                                        Colorectal                                    C18, C19, C20
                                                                        Liver                                         C22
                                                                        Other sites in GI tract                       C15--C17, C21, C23--C26
                                                                                                                       
  Respiratory and intra-thoracic organs                                 C30--C39                                      
  Bone and articular cartilage                                          C40--C41                                      
  Melanoma of skin                                                      C43                                           
  Mesothelial and soft tissue                                           C45--C49                                      
  Breast                                                                C50                                           
  Genitourinary organs                                                  C51--C68                                      
                                                                        Cervix                                        C53
                                                                        Ovary                                         C56
                                                                        Testis                                        C62
                                                                        Other sites                                   C51, C52, C54, C55, C57--C61, C63--C68
                                                                                                                       
  Eye, brain, and other parts of CNS                                    C69--C72                                      
  Thyroid and other endocrine glands                                    C73--C75                                      
  Malignant neoplasms of lymphoid, haematopoietic, and related tissue   C81--C96                                      
                                                                        Lymphoid leukaemia                            C91
                                                                        Myeloid and monocytic leukaemia               C92, C93
                                                                        Hodgkin\'s lymphoma                           C81
                                                                        Non-Hodgkin\'s lymphoma                       C82, C83, C84, C85
                                                                        Other and unspecified lympho-haematopoietic   C88, C90, C94, C95, C96
                                                                                                                       
  Other malignant neoplasms                                             C44, C76--C80, C97                            
  Benign neoplasms and neoplasms of uncertain behaviour                 D10-D48                                       
                                                                        Eye, brain, and other parts of CNS            D31, D32, D33, D42, D43
                                                                        Other sites                                   D10-D30, D34-D41, D44-D48

###### 

Number of deaths (*N*) and mortality rates (*R*) per million person--years at risk by sex and diagnostic group at ages 13--29 years in England and Wales, 1981--2005

                                                                                                                      **Male**   **Female**   **Persons**   ***P*-value**                  
  -------------------------------------------------------------------- --------------------------------------------- ---------- ------------ ------------- --------------- -------- ------ ----------
  Lip, oral cavity and pharynx                                                                                          194         1.3           98             0.6         292     1.0    \<0.0001
  Digestive organs                                                                                                      765         4.9           571            3.7         1336    4.3    \<0.0001
                                                                       Colorectal                                       300         1.9           206            1.4         506     1.6    \<0.0001
                                                                       Liver                                            164         1.1           148            1.0         312     1.0     0.4268
                                                                       Other sites in GI tract                          301         1.9           217            1.4         518     1.7     0.0003
  Respiratory and intrathoracic organs                                                                                  257         1.7           162            1.1         419     1.4    \<0.0001
  Bone and articular cartilage                                                                                          993         6.5           632            4.3         1625    5.4    \<0.0001
  Melanoma of skin                                                                                                      420         2.7           364            2.4         784     2.5     0.0526
  Mesothelial and soft tissue                                                                                           620         4.0           462            3.1         1082    3.5    \<0.0001
  Breast                                                                                                                 1          0.0           719            4.6         720     2.3    \<0.0001
  Genitourinary organs                                                                                                  783         5.1          1376            8.9         2159    7.0    \<0.0001
                                                                       Cervix                                           ---         ---           773            5.0         773     5.0      ---
                                                                       Ovary                                            ---         ---           410            2.7         410     2.7      ---
                                                                       Testis                                           621         4.0           ---            ---         621     4.0      ---
                                                                       Other sites                                      162         1.0           193            1.3         355     1.2     0.0806
  Malignant neoplasms of CNS                                                                                            1531        10.0         1068            7.1         2599    8.5    \<0.0001
  Thyroid and other endocrine glands                                                                                    150         1.0           139            0.9         289     1.0     0.6136
  Malignant neoplasms of lymphoid, haematopoietic and related tissue                                                    4410        28.7         2610           17.3         7020    23.1   \<0.0001
                                                                       Lymphoid leukaemia                               1308        8.6           620            4.2         1928    6.4    \<0.0001
                                                                       Myeloid and monocytic leukaemia                  1154        7.5           844            5.6         1998    6.6    \<0.0001
                                                                       Hodgkin\'s lymphoma                              762         4.9           516            3.4         1278    4.2    \<0.0001
                                                                       Non-Hodgkin\'s lymphoma                          1037        6.7           548            3.6         1585    5.2    \<0.0001
                                                                       Other and unspecified lympho-haematopoietic      149         1.0           82             0.6         231     0.8    \<0.0001
  Other malignant neoplasms                                                                                             522         3.4           304            2.0         826     2.7    \<0.0001
  Benign neoplasms and neoplasms of uncertain behaviour                                                                 489         3.2           386            2.6         875     2.9     0.0011
                                                                       Eye, brain, and other parts of CNS               204         1.3           184            1.2         388     1.3     0.3823
                                                                       Other sites                                      285         1.9           202            1.4         487     1.6     0.0003
  All groups                                                                                                           11 135       72.4         8891           58.6        20 026   65.6   \<0.0001

###### 

Number of deaths (*N*) and mortality rates (*R*) per million person--years at risk by age and diagnostic group at ages 13--29 years in England and Wales, 1981--2005

                                                                                                                      **13--14**   **15--19**   **20--24**   **25--29**   **P-value**   **PCYA^a^**                                       
  -------------------------------------------------------------------- --------------------------------------------- ------------ ------------ ------------ ------------ ------------- ------------- ------ ------ ---------- ----------- ----------------
  Lip, oral cavity and pharynx                                                                                            19          0.6           68          0.8           88            1.0       117    1.3     0.0006    5.52^\*^     (2.82,8.30)
  Digestive organs                                                                                                        26          0.8          147          1.7           358           4.0       805    8.7    \<0.0001   18.71^\*^   (17.47,19.97)
                                                                       Colorectal                                         8           0.2           46          0.5           131           1.4       321    3.5    \<0.0001   21.97^\*^   (18.19,25.88)
                                                                       Liver                                              14          0.4           66          0.8           99            1.1       133    1.4    \<0.0001   8.03^\*^     (5.87,10.25)
                                                                       Other sites in GI tract                            4           0.1           35          0.4           128           1.4       351    3.8    \<0.0001   29.03^\*^   (24.33,33.90)
  Respiratory and intrathoracic organs                                                                                    10          0.3           48          0.6           111           1.2       250    2.7    \<0.0001   17.66^\*^   (14.82,20.57)
  Bone and articular cartilage                                                                                           199          6.0          673          7.8           503           5.6       250    2.7    \<0.0001   −7.63^\*^   (−10.43,−4.75)
  Melanoma of skin                                                                                                        7           0.2           60          0.7           239           2.6       478    5.2    \<0.0001   27.63^\*^   (21.44,34.13)
  Mesothelial and soft tissue                                                                                             71          2.1          282          3.3           361           4.0       368    4.0    \<0.0001   3.75^\*^     (1.63,5.91)
  Breast                                                                                                                  0           0.0           9           0.1           72            0.8       639    6.9    \<0.0001   49.81^\*^   (44.42,55.42)
  Genitourinary organs                                                                                                    32          1.0          186          2.2           562           6.2       1379   14.9   \<0.0001   22.21^\*^   (20.42,24.02)
                                                                       Cervix                                             0           0.0           6           0.1           123           2.7       644    13.9   \<0.0001   54.12^\*^   (47.02,61.56)
                                                                       Ovary                                              11          0.7           58          1.4           124           2.8       217    4.7    \<0.0001   14.67^\*^   (11.83,17.59)
                                                                       Testis                                             2           0.1           73          1.7           216           4.8       330    7.1    \<0.0001   26.51^\*^   (17.88,35.77)
                                                                       Other sites                                        19          0.6           49          0.6           99            1.1       188    2.0    \<0.0001   11.85^\*^    (8.72,15.07)
  Malignant neoplasms of CNS                                                                                             260          7.8          570          6.6           721           8.0       1048   11.3   \<0.0001   3.85^\*^     (2.03,5.71)
  Thyroid and other endocrine glands                                                                                      29          0.9           82          0.9           83            0.9        95    1.0     0.8513      0.91       (−1.64,3.52)
  Malignant neoplasms of lymphoid, haematopoietic and related tissue                                                     543          16.2         1864         21.6         2129          23.5       2484   26.8   \<0.0001   3.13^\*^     (2.05,4.23)
                                                                       Lymphoid leukaemia                                261          7.8          768          8.9           536           5.9       363    3.9    \<0.0001   −6.36^\*^   (−8.17,−4.52)
                                                                       Myeloid and monocytic leukaemia                   147          4.4          478          5.5           616           6.8       757    8.2    \<0.0001   4.50^\*^     (3.75,5.27)
                                                                       Hodgkin\'s lymphoma                                20          0.6          207          2.4           451           5.0       600    6.5    \<0.0001   15.88^\*^   (11.04,20.94)
                                                                       Non-Hodgkin\'s lymphoma                            78          2.3          340          3.9           466           5.2       701    7.6    \<0.0001   7.97^\*^     (6.52,9.43)
                                                                       Other and unspecified lympho-haematopoietic        37          1.1           71          0.8           60            0.7        63    0.7     0.0803      −2.12      (−6.45,2.41)
  Other malignant neoplasms                                                                                               27          0.8          135          1.6           218           2.4       446    4.8    \<0.0001   13.80^\*^   (10.97,16.69)
  Benign neoplasms and neoplasms of uncertain behaviour                                                                   89          2.7          199          2.3           250           2.8       337    3.6    \<0.0001   3.36^\*^     (2.02,4.72)
                                                                       Eye, brain, and other parts of CNS                 42          1.3           78          0.9           105           1.2       163    1.8    \<0.0001   4.58^\*^     (1.19,8.08)
                                                                       Other sites                                        47          1.4          121          1.4           145           1.6       174    1.9     0.0526    2.41^\*^     (0.91,3.93)
  All groups                                                                                                             1312         39.2         4323         50.0         5695          63.0       8696   93.8   \<0.0001   6.53^\*^     (5.80,7.26)

Percentage change per year of age.

^\*^Denotes significance at the 5% level.

###### 

Number of deaths (*N*) and mortality rates (*R*) per million person--years at risk by time period and diagnostic group at ages 13--29 years in England and Wales, 1981--2005

                                                                                      **1981--1985**   **1986--1990**   **1991--1995**   **1996--2000**   **2001--2005**   **P-value**   **APC^a^**                                                         
  --------------------------------------------- ------------------------------------ ---------------- ---------------- ---------------- ---------------- ---------------- ------------- ------------ ------ ------ ------ ---------- ---------- ----------- ---------------
  Lip, oral cavity and pharynx                                                              63              1.0               69              1.0               53             0.9           57       1.0     50    0.9     0.7776     0.5251      −0.54     (−1.64,0.56)
  Digestive organs                                                                         298              4.8              317              4.8              253             3.9          247       4.2    221    3.9     0.0226     0.0053    −0.92^\*^   (−1.82,0.00)
                                                Colorectal                                 116              1.9              120              1.8               82             1.2          104       1.8     84    1.5     0.0330     0.1086      −0.41     (−1.87,1.06)
                                                Liver                                       66              1.0               71              1.1               58             0.9           52       0.9     65    1.1     0.6814     0.9109      −0.13     (−1.86,1.63)
                                                Other sites in GI tract                    116              1.9              126              1.9              113             1.7           91       1.5     72    1.3     0.0466     0.0028    −1.66^\*^   (−3.05,−0.25)
  Respiratory and intrathoracic organs                                                     139              2.3               90              1.4               74             1.1           63       1.1     53    0.9    \<0.0001   \<0.0001   −4.26^\*^   (−5.56,−2.94)
  Bone and articular cartilage                                                             414              6.2              331              5.2              280             4.8          280       5.1    320    5.6     0.0104     0.1444      −0.49     (−1.31,0.34)
  Melanoma of skin                                                                         167              2.7              165              2.4              183             2.8          134       2.3    135    2.4     0.3428     0.2319      −0.64     (−1.69,0.43)
  Mesothelial and soft tissue                                                              231              3.6              258              3.9              232             3.8          190       3.4    171    3.0     0.0648     0.0339      −0.86     (−1.76,0.05)
  Breast                                                                                   176              3.0              174              2.6              151             2.2          127       2.0     92    1.6    \<0.0001   \<0.0001   −2.62^\*^   (−3.48,−1.75)
  Genitourinary organs                                                                     623              10.1             560              8.4              412             6.2          311       5.2    253    4.5    \<0.0001   \<0.0001   −4.24^\*^   (−4.90,−3.56)
                                                Cervix                                     207              7.0              199              5.9              159             4.6          115       3.7     93    3.3    \<0.0001   \<0.0001   −4.07^\*^   (−5.20,−2.92)
                                                Ovary                                      116              3.7               87              2.6               85             2.6           70       2.4     52    1.8     0.0003    \<0.0001   −2.80^\*^   (−4.02,−1.57)
                                                Testis                                     207              6.6              183              5.4              106             3.3           75       2.6     50    1.8    \<0.0001   \<0.0001   −6.31^\*^   (−7.48,−5.11)
                                                Other sites                                 93              1.5               91              1.4               62             1.0           51       0.9     58    1.0     0.0039     0.0009    −2.60^\*^   (−4.10,−1.07)
  Eye, brain, and other parts of CNS                                                       559              8.8              609              9.4              534             8.7          435       7.6    462    8.1     0.0170     0.0141    −0.74^\*^   (−1.47,−0.01)
  Thyroid and other endocrine glands                                                        62              1.0               64              1.0               70             1.2           50       0.9     43    0.8     0.2553     0.2294      −0.77     (−3.11,1.62)
  Lymphoid, haematopoietic and related tissue                                              1858             28.8             1636             25.1             1461           23.8          1106      19.7   959    16.9   \<0.0001   \<0.0001   −2.57^\*^   (−2.93,−2.22)
                                                Lymphoid leukaemia                         469              7.1              463              7.3              385             6.6          346       6.3    265    4.6    \<0.0001   \<0.0001   −1.81^\*^   (−2.62,−0.99)
                                                Myeloid and monocytic leukaemia            555              8.6              463              7.1              387             6.3          312       5.5    281    4.9    \<0.0001   \<0.0001   −2.70^\*^   (−3.42,−1.97)
                                                Hodgkin\'s lymphoma                        397              6.3              335              5.0              270             4.2          139       2.4    137    2.4    \<0.0001   \<0.0001   −5.12^\*^   (−6.07,−4.15)
                                                Non-Hodgkin\'s lymphoma                    362              5.6              331              5.0              382             6.0          271       4.8    239    4.2    \<0.0001    0.0008    −1.20^\*^   (−2.11,−0.28)
                                                Other and unspecified                       75              1.2               44              0.7               37             0.6           38       0.7     37    0.6     0.0029     0.0034    −3.31^\*^   (−5.26,−1.32)
  Other malignant neoplasms                                                                166              2.6              141              2.1              195             3.0          166       2.8    158    2.8     0.0189     0.1097      0.46      (−0.81,1.75)
  Benign and uncertain behaviour                                                           235              3.7              145              2.2              172             2.9          181       3.2    142    2.5    \<0.0001    0.0435      −1.02     (−2.35,0.32)
                                                Eye, brain, and other parts of CNS         112              1.8               61              0.9               75             1.2           73       1.3     67    1.2     0.0012     0.0690      −1.61     (−3.50,0.32)
                                                Other sites                                123              1.9               84              1.3               97             1.6          108       1.9     75    1.3     0.0075     0.2782      −0.38     (−1.82,1.09)
  All groups                                                                               4991             78.4             4559             69.5             4070           65.2          3347      58.5   3059   53.9   \<0.0001   \<0.0001   −1.86^\*^   (−2.09,−1.62)

Annual percentage change.

^\*^Denotes significance at the 5% level.

###### 

Ranking of selected diagnostic groups based on the number (*N*) of deaths from 1981 to 2005 and ranking based on the number of new cases registered in England from 1979 to 2003 in persons at 13--29 years

                                                 **Mortality**   **Incidence**                            
  --------------------------------------------- --------------- --------------- ---- -------- ------ ---- ------
  Eye, brain, and other parts of CNS                 2473            13.9        1     6003    8.2    4    2.4
  Myeloid and monocytic leukaemia                    1899            10.7        2     3095    4.2    8    1.6
  Lymphoid leukaemia                                 1843            10.4        3     2663    3.7    11   1.4
  Bone and articular cartilage                       1538             8.7        4     2760    3.8    10   1.8
  Non-Hodgkin\'s lymphoma                            1513             8.5        5     4873    6.7    6    3.2
  Hodgkin\'s lymphoma                                1209             6.8        6     9778    13.4   1    8.1
  Mesothelial and soft tissue                        1019             5.7        7     2539    3.5    13   2.5
  Melanoma of skin                                    731             4.1        8     6744    9.3    3    9.2
  Cervix                                              713             4.0        9     5520    7.6    5    7.7
  Breast                                              683             3.9        10    3874    5.3    7    5.7
  Testis                                              590             3.3        11    9757    13.4   2    16.5
  Other sites in GI tract                             487             2.7        12    819     1.1    19   1.7
  Colorectal                                          485             2.7        13    1511    2.1    16   3.1
  Respiratory and intrathoracic organs                402             2.3        14    1051    1.4    18   2.6
  Ovary                                               376             2.1        15    2417    3.3    14   6.4
  Benign and uncertain behaviour - CNS                373             2.1        16    2627    3.6    12   7.0
  Other sites in GU organs                            338             1.9        17    1762    2.4    15   5.2
  Liver                                               295             1.7        18    389     0.5    20   1.3
  Lip, oral cavity, and pharynx                       276             1.6        19    1254    1.7    17   4.5
  Thyroid and other endocrine glands                  272             1.5        20    3063    4.2    9    11.3
  Other and unspecified lympho-haematopoietic         222             1.3        21    381     0.5    21   1.7
  All groups                                        17 737            100             72 880   100         4.1

Percentage of all deaths.

Percentage of all new cases.

Incidence to mortality ratio; number of new cases divided by number of deaths.

###### 

Numbers (*N*) and sex ratios (M:F) by age group for the 10 leading causes of death and all deaths at ages 13--29 years in England and Wales, 2002--2005

                                                    **13--14**   **15--19**   **20--24**   **25--29**   **13--29**                              
  ------------------------------------------------ ------------ ------------ ------------ ------------ ------------ ----- ------ ----- -------- -----
  Transport accidents                                  138          2.7          1441         3.7          1538      5.2   1011   5.2    4128    4.5
  Neoplasms                                            187          1.4          595          1.2          722       1.3   964    1.0    2468    1.2
  Intentional self-harm                                 15          0.9          331          3.1          864       4.3   1113   3.6    2323    3.7
  Diseases of the circulatory system                    52          1.4          277          1.6          392       1.5   643    2.0    1364    1.7
  Mental and behavioural disorders                      18          1.2          157          2.1          479       4.4   709    5.0    1363    4.1
  Diseases of the nervous system                       101          1.5          422          2.2          402       1.8   398    1.6    1323    1.8
  Diseases of the respiratory system                    55          1.4          133          1.3          192       1.1   222    1.6    602     1.3
  Endocrine, nutritional, and metabolic diseases        36          1.8          134          0.8          208       1.3   193    1.1    571     1.1
  Malformations, deformations, and abnormalities        54          1.2          157          1.5          165       1.4   168    1.0    544     1.3
  Diseases of the digestive system                      14          0.6           64          1.2          129       1.3   265    1.8    472     1.5
  Other causes                                         227          1.5          1292         2.4          1965      2.9   2259   2.7    5743    2.6
  All deaths                                           897          1.5          5003         2.2          7056      2.7   7945   2.4   20 901   2.4
